Company data
Vertex Pharmaceuticals Incorporated employees and revenue per employee
VRTX · Biotechnology · $128.1B market cap
Vertex Pharmaceuticals Incorporated had 6,400 employees at the end of fiscal Dec 2025, up 4.9% from a year earlier. Revenue for the year was $12.1B, up 9.6% from a year earlier, or $1.89M per employee. Revenue and headcount both grew, and revenue grew faster.
Employees
6,400
+4.9% YoY
Revenue
$12.1B
+9.6% YoY
Revenue / employee
$1.89M
Peer median $602K
Rank in industry
5 of 39
Biotechnology
Headcount against revenue
Both lines start at 100 in the first year we hold, so you can see which one grew faster.
Hover a year for the numbers.
| Year ending | Employees | Revenue | Per employee | Staff YoY | Revenue YoY |
|---|---|---|---|---|---|
| Dec 2025 | 6,400 | $12.1B | $1.89M | +4.9% | +9.6% |
| Dec 2024 | 6,100 | $11.0B | $1.81M | +13.0% | +11.7% |
| Dec 2023 | 5,400 | $9.87B | $1.83M | +12.5% | +10.5% |
| Dec 2022 | 4,800 | $8.93B | $1.86M | +23.1% | +17.9% |
| Dec 2021 | 3,900 | $7.57B | $1.94M | +14.7% | +22.1% |
| Dec 2020 | 3,400 | $6.21B | $1.83M | +13.3% | +49.1% |
| Dec 2019 | 3,000 | $4.16B | $1.39M | +20.0% | +36.6% |
| Dec 2018 | 2,500 | $3.05B | $1.22M | +8.7% | +22.5% |
| Dec 2017 | 2,300 | $2.49B | $1.08M | +7.0% | +46.2% |
| Dec 2016 | 2,150 | $1.70B | $792K | — | — |
Open roles: we have not matched a verified job board for this company yet.
Vertex Pharmaceuticals Incorporated against similar companies
The closest industry peers by revenue, from Biotechnology.
| Company | Employees | Revenue | Revenue / employee | Shape |
|---|---|---|---|---|
| UTHR United Therapeutics Corporation | 1,400 | $3.18B | $2.27M | Efficient growth |
| EXEL Exelixis, Inc. | 1,077 | $2.32B | $2.15M | Leaner |
| VRTX Vertex Pharmaceuticals Incorporated | 6,400 | $12.1B | $1.89M | Efficient growth |
| INCY Incyte Corporation | 2,844 | $5.14B | $1.81M | Efficient growth |
| ALNY Alnylam Pharmaceuticals, Inc. | 2,500 | $3.71B | $1.49M | Efficient growth |
| NBIX Neurocrine Biosciences, Inc. | 2,000 | $2.86B | $1.43M | Efficient growth |
| BMRN BioMarin Pharmaceutical Inc. | 3,221 | $3.22B | $1.00M | Efficient growth |
| REGN Regeneron Pharmaceuticals, Inc. | 15,410 | $14.3B | $931K | Hiring ahead |
| FTRE Fortrea Holdings Inc. | 14,300 | $2.72B | $190K | Leaner |
Questions about Vertex Pharmaceuticals Incorporated
- How many employees does Vertex Pharmaceuticals Incorporated have?
- Vertex Pharmaceuticals Incorporated reported 6,400 employees for the fiscal year ending Dec 2025, in the annual report it filed on February 13, 2026. That is up 4.9% from a year earlier.
- What is Vertex Pharmaceuticals Incorporated's revenue per employee?
- Vertex Pharmaceuticals Incorporated brought in $12.1B of revenue in fiscal Dec 2025, which is $1.89M per employee. That ranks 5 of 39 companies we track in Biotechnology, where the median is $602K.
- Where do these numbers come from?
- Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.
Free game
Think you can pick better than the S&P 500?
Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.
Enter the challengeMore data
Compare VRTX with the rest of the market
See who earns the most per employee, who is hiring, and who is cutting, across every company we track.
Source: employee counts and revenue as stated in Vertex Pharmaceuticals Incorporated's annual reports (Form 10-K), latest filed February 13, 2026. This is data, not a recommendation to buy or sell VRTX.